Literature DB >> 19896806

Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.

Olaf Burkhardt, Vipul Kumar, Stephan Schmidt, Jan T Kielstein, Tobias Welte, Hartmut Derendorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19896806     DOI： 10.1016/j.ijantimicag.2009.09.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  7 in total

1.  Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.

Authors:  Belén Gutiérrez-Gutiérrez; Robert A Bonomo; Yehuda Carmeli; David L Paterson; Benito Almirante; Luis Martínez-Martínez; Antonio Oliver; Esther Calbo; Carmen Peña; Murat Akova; Johann Pitout; Julia Origüen; Vicente Pintado; Elisa García-Vázquez; Oriol Gasch; Axel Hamprecht; Nuria Prim; Mario Tumbarello; German Bou; Pierluigi Viale; Evelina Tacconelli; Manel Almela; Federico Pérez; Helen Giamarellou; José Miguel Cisneros; Mitchell J Schwaber; Mario Venditti; Warren Lowman; Joaquín Bermejo; Po-Ren Hsueh; Marta Mora-Rillo; Irene Gracia-Ahulfinger; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  J Antimicrob Chemother       Date:  2016-02-22       Impact factor: 5.790

2.  Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing.

Authors:  Mathias W Pletz; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-04-20       Impact factor: 17.440

3.  Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients.

Authors:  I Boyadjiev; A Boulamery; N Simon; C Martin; B Bruguerolle; M Leone
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae isolates from elderly patients with pneumonia and acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Emilio Pérez-Trallero; José M Marimón; Julián Larruskain; Marta Alonso; María Ercibengoa
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

5.  Thirty-Day Mortality Rates in Patients with Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteremia Receiving Ertapenem versus Other Carbapenems.

Authors:  Jin Ju Park; Eun-Ju Jung; Jae-Young Kim; Yu Bin Seo; Jacob Lee; Younghee Jung
Journal:  Antimicrob Agents Chemother       Date:  2022-06-16       Impact factor: 5.938

6.  Quantification and validation of ertapenem using a liquid chromatography-tandem mass spectrometry method.

Authors:  S P van Rijn; A M A Wessels; B Greijdanus; D J Touw; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

7.  Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.

Authors:  Fekade Bruck Sime; Michael S Roberts; Sandra L Peake; Jeffrey Lipman; Jason A Roberts
Journal:  Ann Intensive Care       Date:  2012-07-28       Impact factor: 6.925
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.